about
Picolinate-containing macrocyclic Mn2+ complexes as potential MRI contrast agents.H4octapa: highly stable complexation of lanthanide(III) ions and copper(II).A Pyridine-Based Ligand with Two Hydrazine Functions for Lanthanide Chelation: Remarkable Kinetic Inertness for a Linear, Bishydrated Complex.Approaching the Kinetic Inertness of Macrocyclic Gadolinium(III)-Based MRI Contrast Agents with Highly Rigid Open-Chain Derivatives.A bridge to coordination isomer selection in lanthanide(III) DOTA-tetraamide complexes.Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pHDefinition of the Labile Capping Bond Effect in Lanthanide Complexes.Modulation of water exchange in Eu(III) DOTA-tetraamide complexes: considerations for in vivo imaging of PARACEST agents.Effect of the regiochemistry of butyl amide substituents on the solution-state structures of lanthanide(III) DOTA-tetraamide complexes.Lanthanide(III) complexes of tris(amide) PCTA derivatives as potential bimodal magnetic resonance and optical imaging agentsSynthesis and evaluation of lanthanide ion DOTA-tetraamide complexes bearing peripheral hydroxyl groups.Lanthanide dota-like complexes containing a picolinate pendant: structural entry for the design of Ln(III)-based luminescent probes.Investigations into whole water, prototropic and amide proton exchange in lanthanide(III) DOTA-tetraamide chelates.Analysis of the conformational behavior and stability of the SAP and TSAP isomers of lanthanide(III) NB-DOTA-type chelatesStable Mn(2+), Cu(2+) and Ln(3+) complexes with cyclen-based ligands functionalized with picolinate pendant arms.Equilibrium and formation/dissociation kinetics of some Ln(III)PCTA complexes.Synthesis and Characterization of DOTA-(amide)(4) Derivatives: Equilibrium and Kinetic Behavior of Their Lanthanide(III) Complexes.Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.Relaxometric determination of binding between Mn(II)-UDP and Mn(II)-UDP-glucose in aqueous solution.Copper(II) complexes of some N-substituted bis(aminomethyl)phosphinate ligands. An integrated EPR study of microspeciation and coordination modes by the two-dimensional simulation method.A Coordination Chemistry Approach to Fine-Tune the Physicochemical Parameters of Lanthanide Complexes Relevant to Medical Applications.Lanthanide-Based T2ex and CEST Complexes Provide Insights into the Design of pH Sensitive MRI Agents.Physico-chemical properties of MnII complexes formed with cis- and trans-DO2A: thermodynamic, electrochemical and kinetic studies.Complexation of Ln(3+) Ions with Cyclam Dipicolinates: A Small Bridge that Makes Huge Differences in Structure, Equilibrium, and Kinetic Properties.[TlIII(dota)]−: An Extraordinarily Robust Macrocyclic ComplexThe role of the capping bond effect on pyclen natY3+/90Y3+ chelates: full control of the regiospecific N-functionalization makes the differenceMn2+ complexes of open-chain ligands with a pyridine backbone: less donor atoms lead to higher kinetic inertnessLanthanide Complexes Formed with the Tri- and Tetraacetate Derivatives of Bis(aminomethyl)phosphinic Acid: Equilibrium, Kinetic and NMR Spectroscopic StudiesLanthanide(III) Complexes with a Reinforced Cyclam Ligand Show Unprecedented Kinetic InertnessKinetic inertness of the Mn2+ complexes formed with AAZTA and some open-chain EDTA derivativesExpanding the Family of Pyclen-Based Ligands Bearing Pendant Picolinate Arms for Lanthanide ComplexationEnhancement of the Antioxidant Activity and Neurotherapeutic Features through Pyridol Addition to Tetraazamacrocyclic MoleculesDialing in on pharmacological features for a therapeutic antioxidant small moleculeStable and Inert Mn(II)-Based and pH-Responsive Contrast AgentsUnexpected Trends in the Stability and Dissociation Kinetics of Lanthanide(III) Complexes with Cyclen-Based Ligands across the Lanthanide Series
P50
Q30810616-6F8421F7-4A91-48BD-AECC-A06557FF1027Q30894847-9BA1CB99-EC88-407C-8AEC-071DD6247F96Q30962230-F9852EA5-3F13-426C-A93B-E30F4A1477F0Q31026293-DAD633C2-5030-47DD-AE91-B181AD9EE2F3Q31100275-7B4379DF-281D-45B9-A4F8-32E36154B122Q31114276-0EA46852-6AC0-41FD-A991-8F38FF383B82Q31143041-2905539F-0A0A-498C-A062-5A7DF637822BQ33492850-269CAB92-390E-4A21-B211-84A1F9DCDDDAQ33508288-CCC14F62-A288-4A07-B058-4DEE647E1665Q33514505-115A45CD-8B6C-42A0-A4F7-8D9FAAA725F6Q33551906-EF6EE572-6A5D-44F1-831D-20A1A57C6D70Q33859829-68812F86-B7E9-4635-8493-5AA55EE1E570Q33916884-C2CDAD77-A300-4DD3-AB63-C161DF858108Q33983763-CB96FF41-0EF0-4CD0-AF9A-EDD4340AB272Q35558462-6D93259B-98F7-4C26-ABF9-3991AD7A4351Q37002963-C109E11A-530A-4976-8959-96B6796F09D0Q37372737-B768D5D4-8A07-4D25-89B2-BEA839F44F6DQ42837828-C53DE396-15CA-4EFE-868D-9D7ED2D90B05Q43939838-3E383BDB-D0F4-4A71-82FD-8700E6D108B3Q45136145-ADBFA01C-9BAB-485D-9CA2-4E6AEF7E5DE7Q47754310-D7C5F8FB-774F-4F49-800E-A7C22A5B2E81Q47811767-C6F7D0B6-E50C-4BD4-9DAE-32D2B9B58CBBQ52841229-70514918-E5AD-4673-9EBB-08F99E5DB03BQ53253924-9FDDD951-1587-4B50-8C7B-8560B54C3AACQ57526986-A10F23D7-8AA1-48AE-9CB1-43529CC7BD6CQ58931428-14D44FED-93EC-4352-81F4-48FFBE114EAEQ60319094-C0097D41-6E65-40BE-A83F-B26F9FAA1E6CQ60319107-07184BBB-0410-4DF9-B64A-DE2071D9BBC1Q60492265-D3AE9B98-0316-48E7-A861-BBB5DE1503BBQ84968628-DBECC9F2-FFD3-4762-B521-2275E27B0E28Q88915203-99B9CDFE-18E6-4E46-A23E-439911080AF5Q91485481-F9D1DBE3-3BF4-42DD-8AD2-D554FD0FFA4AQ92166084-E2E7A4B3-7CFB-41C7-8010-9A838EADCDCAQ92579829-99262F87-86F5-4326-B235-56E6D134D78FQ94479323-E6BF7F20-8BFF-4EC7-A6E8-6CD8C9B2244E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gyula Tircsó
@ast
Gyula Tircsó
@en
Gyula Tircsó
@es
Gyula Tircsó
@nl
type
label
Gyula Tircsó
@ast
Gyula Tircsó
@en
Gyula Tircsó
@es
Gyula Tircsó
@nl
altLabel
Tircsó G
@en
prefLabel
Gyula Tircsó
@ast
Gyula Tircsó
@en
Gyula Tircsó
@es
Gyula Tircsó
@nl
P1053
D-1677-2015
P106
P2798
P31
P496
0000-0002-7896-7890